skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » AIM Risers and Fallers » AIM round-up: Helium One, Coral Products, Synairgen

Despite spending the bulk of Wednesday’s session in negative territory, the AIM index managed to scrape a positive finish, settling less than a point higher at 1074.48.

  • Helium One +51%
  • Coral Products +31%
  • Kazera Global -14%
  • N4 Pharma -14%
  • Synairgen -11%

Helium One Global [LON: HE1] floated to the top of the board today, adding 51%, following its debut on Friday. This is the product of a merger with Attis one and a refinancing so there appears to be some lag in terms of pricing but with no firm news, the stock could be subject to some volatility in the near term.

Subscribe for more stories like this, 8am weekdays - for free!


Coral Products [LON:CRU] also fared well today, adding 31% in the wake of well received full year results. Whilst sales fell, margins were maintained and despite the cautious tone of the outlook statement, shares still found room for support.

Kazera Global [LON:KZG] was the day’s biggest faller, off by 14%, although the stock put in a strong performance in the latter part of last week off the back of an update from its Namibian operations. Shares remain well above recent levels and this looks like little more than a degree of profit taking.

N4 Pharma [LON:N4P] was also one of the worst performers, off close on 14%, although again it appears to be a case of profit taking after strong gains at the end of last week. Its formulation work update on Dec 3rd seemed to drive a degree of interest, buat again this deserves some context – shares remain up well over 50% on the week.

Synairgen [LON:SNG] made in onto the list yesterday following the rally, but with no supporting news today, the stock again receives our notable mention having slipped 11%. It may be one of the biggest fallers but it’s also important to bear in mind that the applications for their technologies go well beyond COVID.

Related

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.

Comments

Subscribe for more stories like this, 8am weekdays - for free!


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
WisdomTree
ActivTrades
Back To Top